Generally speaking, during early tumor initiation and outgrowth, MIF supports pro-inflammatory immune phenotypes governed by early infiltrating or resident macrophages and inflammatory IL-17 producing T lymphocytes that, collectively, increase inflammation and, likely, cell and tissue damage. Here, MIF is linked to neoplasm.